Understanding epigenetics - The potential rationale for BET inhibition in management of cardiovascular disease.
25 August 2018 (15:50 - 16:10)
Organised by:
About the speaker
Brigham and Women's Hospital, Boston (United States of America)
4 More presentations in this session
Professor E. Stroes (Amsterdam, NL)
A clinical view on BET inhibition in targeting residual risk in cardiovascular disease and diabetes.
Professor K. Ray (London, GB)
Access the full session
The Event
ESC Congress 2018
25 August 2018
15:50 CET
